Negocjatorsp. z o.o.
KRS: NIP: REGON:
Overview
Status
Active
Registry date
2003-10-10
Share capital
50 000,00 PLN
Registered address
Bonifraterska 13/30, 00-203 Warszawa, Poland
Financials
2 of the last 5 financial statements were filed late.
Revenue history
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 252.51MedianUSD 64.65kAverageUSD 231.88k
Net profit
This companyUSD -939.35MedianUSD 1.38kAverageUSD 38.39k
Operating costs
This companyUSD 1.19kMedianUSD 61.42kAverageUSD 191.69k
Assets
This companyUSD 19.28kMedianUSD 135.82kAverageUSD 175.04k
Industry
Authorized Representatives
Marian Adam Woźniak – President of the Management Board
Manner of representation
President of the Management Board individually; commercial proxy individually
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Mariusz Andrzej Mazurek (53) | 25 | $3,376.55 | 25% |
Tomasz Konrad Szeler | 25 | $3,376.55 | 25% |
Marian Adam Woźniak (77) | 45 | $6,077.80 | 45% |
Others | 5 | $675.31 | 5% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 1996-01-01.
No bank accounts reported to the VAT Taxpayer Register.
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Pit-RadwarS.A. | $204,620,378.98 | pitradwar.com | ||
| GenomedS.A. | $7,373,750.46 | genomed.pl | ||
| Codeit4us Rndsp. z o.o. | $152,435.96 | codeit4us.com | ||
| VB IdeaP.S.A. | $44,631.63 | vbidea.pl | ||
| NanovelosS.A. | $24,842.03 | nanovelos.com | ||
| Bio2materialssp. z o.o. | $14,121.59 | bio2materials.com | ||
| Nanostalsp. z o.o. | $8,607.48 | nanostal.com | ||
| IncellvuS.A. | $6,985.93 | incellvu.pl | ||
| NanotheaS.A. | $115.78 | nanothea.com | ||
| MolecureS.A. | $10.77 | molecure.com |
Change history
| Date | Event | |
|---|---|---|
| 2005-03-10 | PKD change (Added: 80.4) | |
| 2004-03-23 | PKD change (Added: 51.70.A, 51.70.B, 67.13.Z, 71.33.Z, 72.30.Z, 72.40.Z, 72.60.Z, 74.40.Z, 74.50, 74.83.Z, 74.84.B, 92.31.E, 92.40.Z) | |
| 2003-10-10 | Entered in the register |
FAQ
The company was registered in the Polish National Court Register (KRS) on October 10, 2003.
The headquarters is located at: Bonifraterska 13, 00-203 Warszawa.
The management board consists of: Marian Adam Woźniak (President of the Management Board).
The share capital of the company is PLN 50,000 (approx. $13,506).
The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.
In 2025, the company generated total revenue of $253, representing an increase of 16658.3% compared to 2024.
No, in 2025 the company was not profitable, reporting a net loss of $939. For comparison, in 2024 the loss was $1,185, meaning the company reduced its loss by 20.9%.
The largest operating cost category falls under external services. This category amounted to $1,192 in 2025, representing 100% of all operating expenses.
Last updated: 2026-07-16